In France, the Government Plan for Combating Drugs and Addictive Behaviours 2013-17 is the responsibility of the Inter-ministerial Mission for Combating Drugs and Addictive Behaviours (MILDECA). The Government Plan addresses the use of illicit and licit substances (narcotics, alcohol, tobacco, psychotropic medicines and new synthetic substances) and non-substance-related addictive behaviours (gambling, gaming, doping). It has three main priorities, which are addressed across five areas of action that structure the Government Plan: (i) promoting prevention, care and risk reduction; (ii) stepping up the fight against trafficking; (iii) improving the application of the law; (iv) basing policies for combating drugs and addictive behaviours on research and evaluation studies; and (v) reinforcing coordination at the national and international levels. The Government Plan is supported by two consecutive action plans, covering 2013-15 and 2016-17. Both action plans detail specific objectives and actions for these periods, identify key stakeholders and detail the planned timelines and expected outcomes for delivering the strategy.
An intervention-based external evaluation of four priority areas (two per action plan) of the Government Plan was commissioned to examine the relevance of new experimental approaches (e.g. peer-led prevention, community action against drug trafficking). This external evaluation was complemented by an internal indicator-driven evaluation examining the effectiveness of the Government Plan in achieving the stated objectives.
France’s drug policy is coordinated at the national level by MILDECA, which is the responsibility of the prime minister and prepares all government decisions on drug issues. MILDECA reports to the prime minister and is tasked with the organisation and coordination of France’s policies against drugs and addictive behaviours. Its mandate covers the use of illicit and licit substances and non-substance-related addictive behaviours. Throughout France and its territories, MILDECA territorial representatives (chefs de projet) are responsible for coordinating drug policy at territorial level.